- Home
- RFL vs BLIV Comparison
RFL vs BLIV Comparison
Compare RFL & BLIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFL
- BLIV
- Stock Information
- Founded
- RFL 2017
- BLIV 2014
- Country
- RFL United States
- BLIV Singapore
- Employees
- RFL N/A
- BLIV N/A
- Industry
- RFL Real Estate
- BLIV
- Sector
- RFL Finance
- BLIV
- Exchange
- RFL Nasdaq
- BLIV NYSE
- Market Cap
- RFL 48.4M
- BLIV 39.8M
- IPO Year
- RFL N/A
- BLIV 2025
- Fundamental
- Price
- RFL $1.66
- BLIV $3.60
- Analyst Decision
- RFL
- BLIV
- Analyst Count
- RFL 0
- BLIV 0
- Target Price
- RFL N/A
- BLIV N/A
- AVG Volume (30 Days)
- RFL 450.8K
- BLIV 43.0K
- Earning Date
- RFL 06-11-2025
- BLIV 01-01-0001
- Dividend Yield
- RFL N/A
- BLIV N/A
- EPS Growth
- RFL N/A
- BLIV N/A
- EPS
- RFL N/A
- BLIV N/A
- Revenue
- RFL $732,000.00
- BLIV $1,355,200.00
- Revenue This Year
- RFL N/A
- BLIV N/A
- Revenue Next Year
- RFL N/A
- BLIV N/A
- P/E Ratio
- RFL N/A
- BLIV N/A
- Revenue Growth
- RFL 35.56
- BLIV N/A
- 52 Week Low
- RFL $1.27
- BLIV $2.69
- 52 Week High
- RFL $3.19
- BLIV $6.40
- Technical
- Relative Strength Index (RSI)
- RFL 46.95
- BLIV N/A
- Support Level
- RFL $1.41
- BLIV N/A
- Resistance Level
- RFL $1.70
- BLIV N/A
- Average True Range (ATR)
- RFL 0.28
- BLIV 0.00
- MACD
- RFL -0.05
- BLIV 0.00
- Stochastic Oscillator
- RFL 11.63
- BLIV 0.00
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.